[1]
Maupetit, P. New constituents in olibanum resinoid and essential oils. Perf. Flav., 1984, 9, 19-37.
[2]
Leung, A.Y.; Foster, S. Encyclopaedia of natural ingredients used in food, drugs and cosmetics; New York, 1996.
[3]
Lemenih, M.; Teketay, D. Frankincense and myrrh resources of Ethiopia: II. Medicinal and industrial uses. Ethiop. J. Health Sci., 2003, 26, 161-172.
[4]
Kirtikar, K.R.; Basu, B.D. Indian Medicinal Plants, 2nd ed; Delhi, India, 1935.
[5]
Shao, Y.; Ho, C.T.; Chin, C.K.; Badmaev, V.; Ma, W.; Huang, M.T. Inhibitory activity of boswellic acids from Boswellia serrata against human leukaemia HL-60 cells in culture. Planta Med., 1998, 64, 328-331.
[6]
Liu, J.J.; Huang, B.; Hooi, S.C. Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells. Br. J. Pharmacol., 2006, 148, 1099-1107.
[7]
Huang, M.T.; Badmaev, V.; Ding, Y.; Liu, Y.; Xie, J.G.; Ho, C.T. Anti-tumour and anti-carcinogenic activities of triterpenoids, beta-boswellic acid. Biofactors, 2000, 13, 25-230.
[8]
Gupta, I.; Gupta, V.; Parihar, A.; Gupta, S.; Ludtke, R.; Safayhi, H.; Ammon, H.P. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, week clinical study. Eur. J. Med. Res., 1998, 3, 511-514.
[9]
Ammon, H.P. Boswellic acids in chronic inflammatory diseases. Planta Med., 2006, 2, 1100-1116.
[10]
Kimmatkar, N.; Thawani, V.; Hingorani, L.; Khiyani, R. Efficacy and tolerability of Boswellia serrta extract in treatment of osteoarthritis of knee-A randomized double blind placebo controlled trial. Phytomedicine, 2003, 10, 3-7.
[11]
Gupta, I.; Parihar, A.; Malhotra, P.; Gupta, S.; Ludtke, R.; Safayhi, H.; Ammon, H.P. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med., 2001, 67, 391-395.
[12]
Gerhardt, H.; Seifert, F.; Buvari, P.; Vogelsang, H.; Repges, R. Therapy of active Crohn disease with Boswellia serrata extracts H-15. Z. Gastroenterol., 2001, 39, 11-17.
[13]
Ammon, H.P. Boswellic acids in chronic inflammatory diseases. Planta Med., 2006, 72, 1100-1116.
[14]
Singh, G.B.; Singh, S.; Bani, S. Anti-inflammatory actions of boswellic acids. Phytomedicine, 1996, 3(1), 81-85.
[15]
Ammon, H.P.T.; Mack, T.; Singh, G.B.; Safayhi, H. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of gum resin exudates of Boswellia serrata. Planta Med., 1991, 57, 203-207.
[16]
Ammon, H.P.; Safayhi, H.; Mack, T.; Sabieraj, J. Mechanism of anti-inflammatory actions of curcumine and boswellic acids. J. Ethnopharmacol., 1993, 38, 113-119.
[17]
Siemoneit, U.; Pergola, C.; Jazzar, B.; Northoff, H.; Skarke, C.; Jauch, J. On the interference of boswellic acids with 5-lipoxygenase: Mechanistic studies in vitro and pharmacological relevance. Eur. J. Pharmacol., 2009, 606, 246-254.
[18]
Safayhi, H.; Sailer, E.R.; Ammon, H.P. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-boswellic acid. Mol. Pharmacol., 1995, 47, 1212-1216.
[19]
Abdel-Tawab, M.; Werz, O.; Schubert-Zsilavecz, M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin. Pharmacokinet., 2011, 50, 349-369.
[20]
Skarke, C.; Kuczka, K.; Tausch, L. Increased bioavailability of 11-keto-β-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: Modeling and simulation considerations for evaluating drug exposures. J. Clin. Pharmacol., 2012, 52(10), 1592-1600.
[21]
Tausch, L.; Henkel, A.; Siemoneit, U. Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense. J. Immunol., 2009, 183, 3433.
[22]
Dash, S.; Das, C.; Sahoo, D.C. Phytochemical and anthelmintic screening of crude bark extract of Adenanthera pavonina Linn. Int. J. Pharm. Compd., 2010, 2, 1-4.
[23]
Patil, A.G.; Koli, S.P.; Patil, D.A.; Chandra, N. Phamacognostical standardization and HPTLC finger print of Crataeva tapia Linn. SSP. Odora [Jacob.] Almeida leaves. Int. J. Pharm. Biosci., 2010, 1(2), 1-14.
[24]
Ramya, V.; Dheena, D.V.; Umamaheswari, S. In vitro studies on antibacterial activity and separation of active compounds of selected flower extracts by HPTLC. J. Chem. Pharm. Res., 2010, 2(6), 86-91.
[25]
Gomathi, D.; Ravikumar, G.; Kalaiselvi, M.; Vidya, B.; Uma, C. HPTLC Fingerprinting Analysis of Evolvulus Alsinoides (L.). J. Acute Med., 2012, 2, 77-82.
[26]
Rathee, D.; Thanki, M.; Agarwal, R.; Anandjiwala, S. Simultaneous Quantification of Bergenin, (+)-Catechin, Gallicin and Gallic acid; and quantification of β-sitosterol using HPTLC from Bergenia ciliata (Haw.) Sternb. Forma. Ligulata. Yeo (Pasanbheda). Pharm. Anal. Acta, 2010, 1, 104.
[27]
Chen, S.; Liu, H.; Tian, R.; Yang, D.; Xu, H.; Chan, A.; Xie, P. High performance thin-layer chromatographic fingerprints of isoflavonoids for distinguishing between Radix puerariae Lobate and Radix puerariae Thomsonii. J. Chromatogr. A, 2006, 1121, 114-119.
[28]
Krohn, K.; Rao, M.S.; Raman, N.V.; Khalilullah, M. High-performance Thin Layer Chromatographic analysis of Anti-Inflammatory triterpenoids from Boswellia serrata Roxb. Phytochem. Anal., 2001, 12, 374-376.
[29]
Pawar, R.K.; Sharma, S.; Singh, K.C.; Sharma, R.K. Physio-chemical standardisation and development of HPTLC method for the determination of β-boswellic acid from Boswellia serrata roxb (exudates). Int. J. App. Pharm. Sci., 2011, 3, 8-13.
[30]
Shah, S.A.; Rathod, S.I.; Suhagia, B.N.; Patel, D.A.; Parmar, V.K.; Shah, B.K.; Vaishnavi, V.M. Estimation of boswellic acids from market formulations of Boswellia serrata extract and 11-keto ß- boswellic acid in human plasma by high-performance thin-layer chromatography. J. Chromatogr. B , 2007, 232, 848.
[31]
ICH, Validation of analytical procedures: Text and Methodology (Q2AR1),. 2005.
[32]
Xie, P.; Chen, S.; Liang, Y.; Wang, X.; Tian, R.; Upton, R. Chromatographic fingerprint analysis--a rational approach for quality assessment of traditional Chinese herbal medicine. J. Chromatogr. A, 2006, 1112, 171-180.
[33]
Qiao, C.; Han, Q.; Song, J.; Mo, S.; Kong, L.; Kung, H.; Xu, H. Chemical fingerprint and quantitative analysis of Fructus Psoraleae by high-performance liquid chromatography. J. Sep. Sci., 2007, 30, 813-818.
[34]
Lu, H.; Liang, Y.; Chen, S. HPTLC densitometric quantification of stigmasterol and lupeol from Ficus religiosa. J. Ethnopharmacol., 2006, 105, 436-440.
[35]
Li, K.; Wang, S. Fingerprint chromatogram analysis of extracts from the leaves of Tripterygium wilfordii Hook. F. by high performance liquid chromatography. J. Sep. Sci., 2005, 28, 653-657.
[36]
Anandjiwala, S.; Srinivasa, H.; Rajani, M. Isolation and TLC densitometric quantification of gallicin, gallic acid, lupeol and β-sitosterol from Bergia suffruticosa, a hitherto unexplored plant. Chromatographia, 2007, 66, 725-734.
[37]
Qian, G.; Wang, Q.; Leung, K.; Qin, Y.; Zhao, Z.; Jiang, Z. Quality assessment of Rhizoma et Radix Notopterygii by HPTLC and HPLC fingerprinting and HPLC quantitative analysis. J. Pharm. Biomed. Anal., 2007, 44, 812-817.
28
2
1